MEGAN BRADY: Open Payments
NPI 1043991920 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,217 in 173 payments from 20 companies in 2025. Trend: 2023 $678 · 2024 $2,763 · 2025 $3,217
Food & beverage: $3,217
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 14 | $349 |
| Lundbeck LLC | 18 | $346 |
| Otsuka America Pharmaceutical, Inc. | 15 | $325 |
| ABBVIE INC. | 16 | $291 |
| Alkermes, Inc. | 17 | $270 |
| Axsome Therapeutics, Inc. | 17 | $249 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $201 |
| Vanda Pharmaceuticals Inc. | 15 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $187 |
| Corium, LLC | 8 | $186 |
Products named: REXULTI, INGREZZA, VRAYLAR, TRINTELLIX, ARISTADA, FANAPT, CAPLYTA, Azstarys.
Industry payments across TX — which companies pay providers there.
